<p>Models of DBL3X in which the intensity of the gray and blue indicates reactivity of plasma tested on a peptide array (PepScan scores). Gray indicates lowest scores and dark blue indicates highest scores. (A and C–I) represent reactivity in eight individual plasma samples. (B) shows the reactivity in the same plasma as tested in (A), but the model has been rotated 180 degrees. Arrow 1 indicates a highly recognized conserved α-helix region, which was not predicted to be an epitope by BepiPred and was characterized by low dN/dS ratios and low sequence variation. Arrow 2 indicates another α-helix with a predicted B cell epitope containing some residues with high sequence variation. Variable regions V1 and V2 are fairly well recognized by mos...
<p>(<i>A</i>) 3D model for DBL2X domain. (<i>B</i>) Crystal structure of DBL3X domain (PDB 3BQK). Se...
The autoantigen of anti-glomerular basement membrane (GBM) disease has been identified as the non-co...
<p>Reactivity of peptide C6_30_cons against the sera from mice infected with Colombiana (A), Y (B), ...
<div><p>(A) PepScan IgG reactivity in a Ghanaian pool of pregnancy plasma before (red) and after (bl...
<div><p>(A) dN/dS ratio per amino acid based on an alignment of 47 DBL3X sequences. dN/dS ratio high...
<p>(A) Peptide-region P22–P26 mapped on a DBL4ε-FCR3 model. (B) FCR3 and 3D7 sequences aligned with ...
<div><p>(A) Binding assay. DBL3X binds to CSA in a protein concentration-specific manner. ELISA plat...
<p>(A) Reactivity of DBL4ε anti<b>-</b>sera to each peptide is shown as the average O.D. values for ...
A important step in designing peptide vaccines involves the identification of antigenic regions in a...
A important step in designing peptide vaccines involves the identification of antigenic regions in a...
<p>The distributions of the reactivities are shown where the left edge of each box equals the 25th p...
<p>A) Promising replacements in the sequence of D3 were selected via PepSpots peptide array. Binding...
<p>(A) Immunogenicity screening for three DRB1 alleles (DRB1*15:01, DRB1*03:01 and DRB1*07:01) with ...
<p>(A) Slot blot (B) ELISA of reactivity of monoclonal antibody against FrpB F3-3 (•, +Fe; ▪, −Fe). ...
<p>On the DBL3X structure of DBL6ε (PDB: 3BQK) were localized: <b>A</b>) variable blocks coloured in...
<p>(<i>A</i>) 3D model for DBL2X domain. (<i>B</i>) Crystal structure of DBL3X domain (PDB 3BQK). Se...
The autoantigen of anti-glomerular basement membrane (GBM) disease has been identified as the non-co...
<p>Reactivity of peptide C6_30_cons against the sera from mice infected with Colombiana (A), Y (B), ...
<div><p>(A) PepScan IgG reactivity in a Ghanaian pool of pregnancy plasma before (red) and after (bl...
<div><p>(A) dN/dS ratio per amino acid based on an alignment of 47 DBL3X sequences. dN/dS ratio high...
<p>(A) Peptide-region P22–P26 mapped on a DBL4ε-FCR3 model. (B) FCR3 and 3D7 sequences aligned with ...
<div><p>(A) Binding assay. DBL3X binds to CSA in a protein concentration-specific manner. ELISA plat...
<p>(A) Reactivity of DBL4ε anti<b>-</b>sera to each peptide is shown as the average O.D. values for ...
A important step in designing peptide vaccines involves the identification of antigenic regions in a...
A important step in designing peptide vaccines involves the identification of antigenic regions in a...
<p>The distributions of the reactivities are shown where the left edge of each box equals the 25th p...
<p>A) Promising replacements in the sequence of D3 were selected via PepSpots peptide array. Binding...
<p>(A) Immunogenicity screening for three DRB1 alleles (DRB1*15:01, DRB1*03:01 and DRB1*07:01) with ...
<p>(A) Slot blot (B) ELISA of reactivity of monoclonal antibody against FrpB F3-3 (•, +Fe; ▪, −Fe). ...
<p>On the DBL3X structure of DBL6ε (PDB: 3BQK) were localized: <b>A</b>) variable blocks coloured in...
<p>(<i>A</i>) 3D model for DBL2X domain. (<i>B</i>) Crystal structure of DBL3X domain (PDB 3BQK). Se...
The autoantigen of anti-glomerular basement membrane (GBM) disease has been identified as the non-co...
<p>Reactivity of peptide C6_30_cons against the sera from mice infected with Colombiana (A), Y (B), ...